Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
15.06
+1.32 (9.61%)
At close: Aug 26, 2026, 4:00 PM EDT
14.25
-0.81 (-5.38%)
Pre-market: Aug 27, 2026, 7:19 AM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $969.83 million as of August 27, 2026. Its market cap has increased by 1,502.59% in one year.
Market Cap
969.83M
Enterprise Value
763.72M
1-Year Change
1,502.59%
Ranking
Category
Stock Price
$15.06
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has increased from $553.50M to $969.83M, an increase of 75.22%. That is a compound annual growth rate of 21.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 969.83M | 1,750.88% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 959.27M |
| Design Therapeutics | 953.12M |
| Cybin | 951.24M |
| Climb Bio | 941.95M |
| Ardelyx | 931.96M |
| Aclaris Therapeutics | 928.83M |
| Olema Pharmaceuticals | 912.60M |
| Faeth Therapeutics | 896.92M |